Captopril and renal survival in patients with human immunodeficiency virus nephropathy

American Journal of Kidney Diseases

Volumn 28, Issue 2, 1996, Pages 202-208

  Kimmel, Paul L ^a   Mishkin, Gary J ^a   Umana, Walter O ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antiretroviral drug; captopril; chronic kidney disease; focal glomerulosclerosis; human immunodeficiency virus; proteinuria

Indexed keywords

CAPTOPRIL;

ADULT; AIDS RELATED COMPLEX; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOCAL GLOMERULONEPHRITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FUNCTION; MALE; ORAL DRUG ADMINISTRATION; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT OUTCOME;

EID: 0029818094     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90302-9     Document Type: Article

References (50)

1. Bourgoignie JJ: Renal complications of HIV-type infection. Kidney Int 37:1571-1584, 1990
2. Cantor ES, Kimmel PL, Bosch JP: Effect of race on the expression of AIDS associated nephropathy. Arch Intern Med 151:125-128, 1991
3. Cohen AH, Nast CC: HIV-associated nephropathy. A unique combined glomerular, tubular and interstitial lesion. Mod Pathol 1:87-97, 1988
4. Glassock RJ, Cohen AH, Danovitch G, Parsa KP: HIV infection and the kidney. Ann Intern Med 112:35-49, 1990
5. Langs C, Gallo GR, Schacht RG, Sidhu G, Baldwin DS: Rapid renal failure in AIDS focal glomerulosclerosis. Arch Intern Med 150:287-292, 1990
6. Alter MJ, Favero MS, Moyer LA, Blend LA: National surveillance of dialysis associated diseases in the US. ASAIO Trans 37:97-108, 1990
7. Reiser IW, Shapiro WB, Porush JG: Incidence and epidemiology of HIV infection in 320 patients treated in an inner city hemodialysis center. Am J Kidney Dis 15:26-31, 1990
8. Ortiz C, Meneses R, Jaffe D, Fernandez JA, Perez G, Bourgoignie JJ: Outcome of patients with HIV on maintenance hemodialysis. Kidney Int 34:248-253, 1988
9. Kimmel PL, Umana WO, Simmens SJ, Watson J, Bosch JP: Continuous ambulatory peritoneal dialysis and survival of HIV infected patients with end stage renal disease. Kidney Int 44:373-378, 1993
10. Vijayvargiya R, Bosch JP: Dialysis and transplantation in patients with HIV infection, in Kimmel PL, Berns JS (eds): Renal and Urologic Aspects of HIV Infection. New York, NY, Churchill Livingstone, 1995, pp 253-278
11. Cook PP, Appel RG: Prolonged clinical improvement in HIV-associated nephropathy with zidovudine therapy. J Am Soc Nephrol 1:842, 1990 (letter)
12. Lam M, Park MC: HIV-associated nephropathy - Beneficial effect of zidovudine therapy. N Engl J Med 323:1775-1776, 1990 (letter)
13. Babut-Gay ML, Echard M, Kleinknecht D, Meyrier A: Zidovudine and nephropathy with HIV infection. Ann Intern Med 111:856-857, 1989 (letter)
14. Michel C, Dosquet P, Ronco P, Mougenot B, Viron B, Mignon F: Nephropathy associated with infection by human immunodeficiency virus: A report on eleven cases including six treated with zidovudine. Nephron 62:434-440, 1992
15. Ifudu O, Rao TKS, Tan CC, Fleischman H, Chirgwin K, Friedman EA: Zidovudine is beneficial in human immunodeficiency virus associated nephropathy. Am J Nephrol 15:217-221, 1995
16. Smith MC, Pawar R, Carey JT, Graham RC Jr, Jacobs GH, Menon A, Salata RA, Seliga R, Kalayjian RC: Effect of corticosteroid therapy on human immunodeficiency virus associated nephropathy. Am J Med 97:145-151, 1994
17. Burns GC, Matute R, Onyema D, Davis I, Toth D: Response to inhibition of angiotensin converting enzyme in human immunodeficiency virus associated nephropathy: A case report. Am J Kidney Dis 23:441-443, 1994
18. Brouhard BH, Irwin KC, Cunningham RJ, Slowe NT: Use of angiotensin-converting enzyme inhibitors in chronic progressive renal disease. Cleve Clin J Med 58:184-190, 1991
19. De Jong PE, Heeg JE, Apperloo AJ, de Zeeuw D: Angiotensin-1 converting enzyme inhibition: Clinical effects in chronic renal disease. Am J Kidney Dis 17:85-88, 1991
20. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
21. Hahn AW, Resink TJ, Bernhardt J, Ferracin F, Buhler FR: Stimulation of autocrine platelet derived growth factor AA heterodimer and transforming growth factor-β in vascular smooth muscle cells. Biochem Biophys Res Commun 178:1451-1458, 1991
22. Stouffer GA, Owens GK: Angiotensin II-induced mitogenesis of SHR rat derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-β. Circ Res 70:820-828, 1992
23. Koibuchi Y, Lee WS, Gibbons GH, Pratt RE: Role of transforming growth factor-β in the cellular growth response to angiotensin II. Hypertension 21:1046-1050, 1993
24. Border WA, Noble NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1285-1292, 1994
25. Bodi I, Kimmel PL, Abraham AA, Sporn M, Klotman PE, Kopp JB: Increased transforming growth factor-β expression in human HIVAN. J Am Soc Nephrol 4:461, 1993 (abstr)
26. Wolf G, Mueller E, Stahl AK, Ziyadeh FN: Angiotensin II-induced hypertrophy of cultured mutine proximal tubular cells is mediated by endogenous transforming growth factor-β. J Clin Invest 92:1366-1372, 1993
27. Sharma SK, Evans DB, Hui JO, Heinrikson RL: Could angiotensin I be produced from a renin substrate by the HIV-1 protease? Anal Biochem 198:363-367, 1991
28. Ouellete DR, Kelly JW, Anders GT: Serum angiotensin converting enzyme level is elevated in patients with HIV infection. Arch Intern Med 152:321-324, 1992
29. Ginsberg JM, Chang BS, Matarese RA, Garella S: Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 309:1543-1546, 1983
30. Kimmel PL, Umana WO, Bosch JP: Abnormal urinary protein excretion in HIV infected patients. Clin Nephrol 39:17-21, 1993
31. Hirsh RP, Reigelman RK: Statistical First Aid: Interpretation of Health Research Data. Boston, MA, Blackwell Scientific Publications, 1992
32. Statistical Applied Software 6.0. SAS/STAT User's Guide. Cary, NC, SAS Institute, Inc, 1992
33. Rao TKS, Friedman EA, Nicastri AD: The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 316:1062-1068, 1987
34. Border WA, Ruoslahti E: TGF-β in disease: The dark side of tissue repair. J Clin Invest 90:1-7, 1992
35. Sharma K, Ziyadeh F: The transforming growth factor-β system and the kidney. Semin Nephrol 13:116-128, 1993
36. Border W, Yamamoto T, Gold L, Nast C, Cohen A: HIVAN is linked to transforming growth factor-β and matrix protein expression in human kidney. J Am Soc Nephrol 4:675, 1993 (abstr)
37. Kekow J, Wachsman W, McCutchan A, Cronin M, Carson DA, Lotz M: Transforming growth factor-B and noncytopathic mechanisms of immunodeficiency in HIV infection. Proc Natl Acad Sci U S A 87:8321-8325, 1990
38. Allen JB, Wong HL, Guyre PM, Simon GL, Wahl SM: Association of circulating receptor FCYRIII+ monocytes in AIDS patients with elevated TGF-β levels. J Clin Invest 87:1773-1779, 1991
39. Shukla RR, Kumar A, Kimmel PL: Transforming growth factor-β increases the expression of HIV-1 gene in transfected human mesangial cells. Kidney Int 44:1022-1029, 1993
40. Rappaport J, Kopp JB, Klotman PE: Host virus interactions and the molecular regulation of HIV-1: Role in the pathogenesis of HIV-associated nephropathy. Kidney Int 46:16-27, 1994
41. Shukla RR, Kimmel PL, Kumar A: Molecular biology of HIV-1 and kidney disease, in Kimmel PL, Berns JS, Stein JH (eds): Renal and Urologic Aspects of HIV Infection. New York, NY, Churchill Livingstone, 1995, pp 77-110
42. Kimmel PL, Phillips TM: Renal tissue HIV peptides are associated with HIV nephropathy. J Am Soc Nephrol 5:353, 1994 (abstr)
43. Phillips TM, Kimmel PL: High performance capillary electrophoretic analysis of inflammatory citokines in human biopsies. J Chromatogr 656:259-266, 1994
44. Bodi I, Abraham AA, Kimmel PL: Macrophages in HIV-associated kidney diseases. Am J Kidney Dis 24:762-767, 1994
45. Kozlowski S, Corr M, Takeshita T, Boyd LF, Pendleton CD, Germain RN, Berzofsky JA, Margulies DH: Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules. J Exp Med 175:1417-1422, 1992
46. Eisenlohr LC, Bacik I, Bennink JR, Bernstein K, Yewdell JW: Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T-lymphocytes. Cell 71:963-972, 1992
47. Friedland J, Setton C, Silverstein E: Induction of angiotensin converting enzyme in human monocytes in culture. Biochem Biophys Res Commun 83:843-849, 1978
48. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F: Angiotensin converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T lymphocytes. Biochem J 290:33-40, 1993
49. Kimmel PL, VedBrat SS, Pierce PF, Umana WO, Shepherd L, Verme DA, Hirsch RP, Hellman KB: Prevalence of viremia in HIV-infected patients with renal disease. Arch Intern Med 155:1578-1584, 1995
50. Kimmel PL, Ferreira-Centeno A, Farkas-Szallasi T, Abraham AA, Garrett CT: Viral DNA in microdissected renal biopsy tissue from HIV infected patients with nephrotic syndrome. Kidney Int 43:1347-1352, 1993